Skip to main content

Table 4 Local recurrence and distant metastasis in TME or LE

From: Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk

Patients

Sex

Age

Operation

Adjuvant therapy

Local recurrence

Distant metastasis

DAV (cm)

Tumor diameter (cm)

T stage

N stage

Resection margin (cm)

LE 1

F

51

TEM

No

Excision site

Lung

5

4.0

T1

n/a

0.1

LE 2

M

31

TEM

CCRT

No

Lung

5

1.0

T1

n/a

0.1

LE 3

F

74

Polypectomy

No

Excision site

Lung

5

3.8

T1

n/a

< 0.1

LE 4

F

26

TRE

No

Excision site

No

3

4.0

T1

n/a

< 0.1

TME 1

M

58

LAR

No

Anastomosis

Liver

3

3.2

T1

N0

0.5

TME 2

F

49

LAR

No

No

PA nodes

8

2.0

T2

N0

1.7

TME 3

M

54

LAR

No

Anastomosis

No

4

2.0

T2

N0

0.7

TME 4

M

71

LAR

No

Presacral

Lung

6

2.0

T2

N0

1.0

TME 5

F

68

LAR

No

No

Lung

5

2.0

T2

N0

0.7

TME 6

F

63

LAR

No

No

Lung

8

2.7

T2

N0

2.0

TME 7

F

55

APR

No

No

Lung

3

2.5

T2

N0

3.0

TME 8

M

75

APR

No

No

Lung

3

2.4

T2

N0

3.0

TME 9

M

76

LAR

No

No

Brain

5

2.1

T2

N1b

0.6

TME 10

M

72

APR

No

No

Lung

2.5

4.5

T1

N0

2.5

  1. APR Abdomino-perineal resection, CCRT concurrent chemoradiation, DAV distance from anal verge, LAR low anterior resection, LE local excision, PA para-aortic, TEM trans-anal endoscopic surgery, TME total mesorectal excision, TRE trans-rectal excision